Profile
Chris Beattie currently works at ViAqua Therapeutics Ltd., as Director from 2021 and AquaBounty Technologies, Inc., as Chief Scientific Officer from 2022.
Chris Beattie active positions
| Companies | Position | Start |
|---|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 2021-12-31 |
ViAqua Therapeutics Ltd.
 ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Director/Board Member | 2021-10-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AQUABOUNTY TECHNOLOGIES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ViAqua Therapeutics Ltd.
ViAqua Therapeutics Ltd. Pharmaceuticals: OtherHealth Technology Viaqua Therapeutics Ltd. engages in the development of drugs and therapeutics for aquaculture. Its platform for treating viral diseases in shellfish and fish utilizes a proprietary RNAi nanoparticle formulation that triggers a cell reaction to disable the viral infection. The company was founded in by Shai Einbinder and Shai Ufaz in September 2014 and is headquartered in Haifa, Israel. | Health Technology |
- Stock Market
- Insiders
- Chris Beattie
